A Lifeline for Affordable Medications: CPPI Endorses the Affordable and Safe Prescription Drug Importation Act of 2025

On May 30, 2025, the Campaign for Personal Prescription Importation (CPPI) proudly announced its endorsement of H.R. 3162, the Affordable and Safe Prescription Drug Importation Act of 2025, introduced by U.S. Rep. Jan Schakowsky.

This groundbreaking legislation, which has garnered a significant list of co-sponsors, represents a vital step toward addressing the skyrocketing cost of prescription drugs in the United States.

Simply put, for millions of Americans struggling to afford life-saving medications, this bill offers hope – and a practical solution to continue to make your ongoing maintenance prescriptions less expensive.

The Affordable and Safe Prescription Drug Importation Act of 2025 amends the Federal Food, Drug, and Cosmetic Act. It will protect and expand Americans’ ability to safely import affordable prescription medications from licensed pharmacies in Canada, the United Kingdom, the European Union, and Switzerland. These countries have rigorous regulatory standards, ensuring that imported medications meet high safety and quality requirements.

For over two decades, personal prescription importation has been a lifeline for Americans, particularly those on fixed incomes managing chronic conditions. CPPI’s most recent national survey highlights the impact: on average, Americans save $4,920 per year by importing medications from Canada compared to U.S. prices.

The need for this legislation is undeniable. In the U.S., some brand-name drugs cost over four times more than in other developed nations, placing an unbearable financial burden on patients. For many, the choice between paying for medications and covering basic necessities like food or rent is a daily reality.

Personal prescription importation has proven to be a safe and reliable solution, with millions of Americans relying on 90-day supplies of maintenance medications to manage conditions like diabetes, hypertension, and heart disease. This bill ensures that this cost-effective pathway remains accessible to us.

At CPPI, we represent thousands of Americans who depend on imported medications to maintain their health and financial stability. Our mission is to advocate for safe, affordable access to prescription drugs, particularly for the elderly and others on fixed incomes who are disproportionately affected by exorbitant U.S. drug prices. The Affordable and Safe Prescription Drug Importation Act of 2025 aligns perfectly with this mission, offering a practical solution to a crisis that affects tens of millions of Americans.

The introduction of this bill comes at a critical time. As pharmaceutical companies continue to raise prices, patients are left scrambling for solutions. Personal prescription importation has a several-decades-long track record of safety and reliability, and this legislation strengthens that framework by ensuring oversight and expanding access.

For those looking to safely import medications today, CPPI provides resources at www.personalimportation.org/find-a-pharmacy, including a list of licensed, certified Canadian pharmacies and tips for selecting a reputable online pharmacy.

We urge Congress to act swiftly to pass H.R. 3162 and provide immediate relief to Americans burdened by high drug costs. This is not just a matter of policy – it’s a matter of health, dignity, and financial well-being. As CPPI’s Executive Director, I call on lawmakers to prioritize their constituents’ needs and support this critical legislation. Together, we can ensure that every American has access to the medications they need to live healthier, fuller lives.